Chances are you have family or friends who have struggled with weight loss for years ... "No one-size-fits-all approach is going to work for everyone because differences exist between us," Roberts ...

Losing weight is tough, both physically and mentally. Here are simple ways to overcome the mindsets that are undermining your ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

Viking Therapeutics shares surge as VK2735 shows significant weight loss in early-stage study ... view and an opportunity to put new cash to work, especially cash that has been sitting on the ...

LONDON, Nov 4 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, was safe and ...

She first joined Vox in 2019, and her work has also appeared in Politico ... it’s not clear Americans actually know what they’re asking for. The answer to the second question is more ...

"First of all, I just want to really start out by apologizing to my teammates, to the city, to the organization," he said. "They put a lot of trust in me with my decision-making, and when they put ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online meetings, phone calls, and ...

Jefferies analyst Roger Song in an investor note said that Viking Therapeutics’ readout for its investigational therapy VK2735 exceeded expectations, with “class-leading” weight loss. Patients on ...